#afib PULSED AF Pilot.N=38: 160±91min (proc), 82±35min(LA dwell), 28±9min(fluoro). Congrats! @atulverma_md @PrashSanders @JohnHummelEP
First-in-Human Experience and Acute Procedural Outcomes Using a Novel Pulsed Field Ablation System: The PULSED AF Pilot Trial.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Dec 2021 – Mar 2024Where it's discussed
-
X / Twitter68 posts
-
News5 articles
-
YouTube2 videos
AI synopsis
What people are saying
Many posts reference the successful outcomes of the PULSED AF trial, highlighting aspects such as '100% pulmonary vein isolation' and 'no serious adverse events', which reflect excitement and promote further discussions. The use of enthusiastic phrases like 'exciting webinar' and 'congrats' fosters a positive tone, signaling the importance of this research in the medical community.
Most discussions express positive reactions towards the findings of the trial, indicating a level of agreement with the authors' conclusions.
There is a high level of curiosity, with many posts promoting webinars and encouraging others to engage with the article.
Discussions show moderate engagement, with participants discussing specific data and results from the trial, although the focus is more on future events than deep analysis.
Users perceive the publication as having a significant influence on the field of atrial fibrillation treatment, especially given the mention of safety and effectiveness.
Abstract in brief
- The PULSED AF Pilot Trial evaluates a novel pulsed field ablation (PFA) system for treating atrial fibrillation, focusing on its feasibility and safety in a clinical setting.
- Thirty-eight patients across six international centers successfully underwent PFA, achieving 100% acute pulmonary vein isolation during procedures.
- The study reported no serious adverse events related to the PFA system within the 30-day follow-up period, demonstrating its potential safety and effectiveness in human applications.
Top posts
Most liked on X and BlueskyPULSED AF Clinical Trial First-in-human Experience: 100% PVI was achieved using only PFA with no PFA system related serious adverse events #AHAJournals #Epeeps https://t.co/NADXbMSjq5 https://t.co/9Y9GIRlyl3
Interested in clinical results for esophageal teeperature with PFA? See our article! https://t.co/YyvwLMtnIj
From CircEP's AFIB advisory board, the next webinar will be on October 26th, 8PM EST [Register: https://t.co/vx0JyfwvHs] @AndreaRussoEP @ElaineWanMD @atulverma_md @dhaines901 @VivekReddyMD @drdevignair @DanielPMorin @wanginnovate [Article: https://t.co/xDI8tsACix] #AHAJournals https://t.co/jL6rGoUAG8
CircA&E's next webinar is coming up! REGISTER HERE [https://t.co/vx0Jyfx3x0] to hear @atulverma_md @dhaines901 @VivekReddyMD @drdevignair discuss recent article, https://t.co/x6NIP9oDpP #AHAJournals #Epeeps @AndreaRussoEP @ElaineWanMD @DanielPMorin @wanginnovate https://t.co/CVFx2MPM0d
First-in-Human Experience and Acute Procedural Outcomes Using #PFA. The PULSED AF Pilot Trial @atulverma_md @PrashSanders @HughCalkinsMD @natale_md @GerdHindricks @CirculationEP #EPeeps
All mentions
Evaluating Pulsed Field Ablation for Atrial Fibrillation Safety and Efficacy
This webinar discusses the PULSED AF Pilot Trial evaluating a novel pulsed field ablation system for atrial fibrillation. It highlights the successful outcomes of 38 patients, achieving 100% acute pulmonary vein…
Evaluating Pulsed Field Ablation System for Atrial Fibrillation
In this Global EP episode, JC Zerpa Acosta MD and Prashanthan Sanders MBBS PhD FHRS discuss the pulsed field ablation (PFA) technology, focusing on its feasibility and safety in treating atrial fibrillation. The PULSED…
RT @atulverma_md: @CircAHA @MDT_EPAblation @dhaines901 @PrashSanders https://t.co/YyvwLMtnIj
RT @atulverma_md: @CircAHA @MDT_EPAblation @dhaines901 @PrashSanders https://t.co/YyvwLMtnIj
Correct link: https://t.co/ucpKnwX6ng
RT @atulverma_md: @CircAHA @MDT_EPAblation @dhaines901 @PrashSanders https://t.co/YyvwLMtnIj
@CircAHA @MDT_EPAblation @dhaines901 @PrashSanders https://t.co/YyvwLMtnIj
RT @AndreaRussoEP: Join us tonight for this exciting webinar with experts in the field: @atulverma_md @VivekReddyMD @dhaines901 @Drdevignai…
RT @AndreaRussoEP: Join us tonight for this exciting webinar with experts in the field: @atulverma_md @VivekReddyMD @dhaines901 @Drdevignai…
RT @CirculationEP: WEBINAR *TONIGHT* at 8PM EST! Register now to join https://t.co/vx0JyfwvHs and read the related article https://t.co/x6N…
RT @CirculationEP: WEBINAR *TONIGHT* at 8PM EST! Register now to join https://t.co/vx0JyfwvHs and read the related article https://t.co/x6N…
RT @CirculationEP: WEBINAR *TONIGHT* at 8PM EST! Register now to join https://t.co/vx0JyfwvHs and read the related article https://t.co/x6N…
RT @CirculationEP: WEBINAR *TONIGHT* at 8PM EST! Register now to join https://t.co/vx0JyfwvHs and read the related article https://t.co/x6N…
RT @CirculationEP: WEBINAR *TONIGHT* at 8PM EST! Register now to join https://t.co/vx0JyfwvHs and read the related article https://t.co/x6N…
WEBINAR *TONIGHT* at 8PM EST! Register now to join https://t.co/vx0JyfwvHs and read the related article https://t.co/x6NIP9o5Ah @AndreaRussoEP @ElaineWanMD will discuss with @atulverma_md #AHAJournals https://t.co/5G1CSwRViv
RT @AndreaRussoEP: Join us tonight for this exciting webinar with experts in the field: @atulverma_md @VivekReddyMD @dhaines901 @Drdevignai…
RT @AndreaRussoEP: Join us tonight for this exciting webinar with experts in the field: @atulverma_md @VivekReddyMD @dhaines901 @Drdevignai…
Join us tonight for this exciting webinar with experts in the field: @atulverma_md @VivekReddyMD @dhaines901 @Drdevignair @ElaineWanMD - Status of PFA. https://t.co/GKbpFDoI7p https://t.co/nnPHbkUnkE https://t.co/nR1gULZlIb
RT @CirculationEP: REGISTER NOW to join our next webinar [https://t.co/vx0JyfO6z0] on Oct 26, and read the related article [https://t.co/x6…
RT @CirculationEP: REGISTER NOW to join our next webinar [https://t.co/vx0JyfO6z0] on Oct 26, and read the related article [https://t.co/x6…
RT @CirculationEP: REGISTER NOW to join our next webinar [https://t.co/vx0JyfO6z0] on Oct 26, and read the related article [https://t.co/x6…
RT @CirculationEP: REGISTER NOW to join our next webinar [https://t.co/vx0JyfO6z0] on Oct 26, and read the related article [https://t.co/x6…
REGISTER NOW to join our next webinar [https://t.co/vx0JyfO6z0] on Oct 26, and read the related article [https://t.co/x6NIP96ubH] Hosted by @AndreaRussoEP @ElaineWanMD #AHAJournals #Epeeps https://t.co/hxuDrrs0bE
RT @CirculationEP: CircA&E's next webinar is coming up! REGISTER HERE [https://t.co/vx0Jyfx3x0] to hear @atulverma_md @dhaines901 @VivekRed…
RT @CirculationEP: CircA&E's next webinar is coming up! REGISTER HERE [https://t.co/vx0Jyfx3x0] to hear @atulverma_md @dhaines901 @VivekRed…
RT @CirculationEP: CircA&E's next webinar is coming up! REGISTER HERE [https://t.co/vx0Jyfx3x0] to hear @atulverma_md @dhaines901 @VivekRed…
CircA&E's next webinar is coming up! REGISTER HERE [https://t.co/vx0Jyfx3x0] to hear @atulverma_md @dhaines901 @VivekReddyMD @drdevignair discuss recent article, https://t.co/x6NIP9oDpP #AHAJournals #Epeeps @AndreaRussoEP @ElaineWanMD @DanielPMorin @wanginnovate https://t.co/CVFx2MPM0d
RT @CirculationEP: From CircEP's AFIB advisory board, the next webinar will be on October 26th, 8PM EST [Register: https://t.co/vx0JyfwvHs…
RT @CirculationEP: From CircEP's AFIB advisory board, the next webinar will be on October 26th, 8PM EST [Register: https://t.co/vx0JyfwvHs…
From CircEP's AFIB advisory board, the next webinar will be on October 26th, 8PM EST [Register: https://t.co/vx0JyfwvHs] @AndreaRussoEP @ElaineWanMD @atulverma_md @dhaines901 @VivekReddyMD @drdevignair @DanielPMorin @wanginnovate [Article: https://t.co/xDI8tsACix] #AHAJournals https://t.co/jL6rGoUAG8
RT @atulverma_md: Interested in clinical results for esophageal teeperature with PFA? See our article! https://t.co/YyvwLMtnIj
RT @atulverma_md: Interested in clinical results for esophageal teeperature with PFA? See our article! https://t.co/YyvwLMtnIj
RT @atulverma_md: Interested in clinical results for esophageal teeperature with PFA? See our article! https://t.co/YyvwLMtnIj
Interested in clinical results for esophageal teeperature with PFA? See our article! https://t.co/YyvwLMtnIj
RT @DebbeMcCall: First-in-Human Experience and Acute Procedural Outcomes Using a Novel Pulsed Field Ablation System. The PULSED AF Pilot Tr…
First-in-Human Experience and Acute Procedural Outcomes Using a Novel Pulsed Field Ablation System. The PULSED AF Pilot Trial https://t.co/HoguM7FmTV https://t.co/cJKX3uRyYb
RT @dambrox: First-in-Human Experience and Acute Procedural Outcomes Using #PFA. The PULSED AF Pilot Trial @atulverma_md @PrashSanders @Hu…
RT @dambrox: First-in-Human Experience and Acute Procedural Outcomes Using #PFA. The PULSED AF Pilot Trial @atulverma_md @PrashSanders @Hu…
RT @dambrox: First-in-Human Experience and Acute Procedural Outcomes Using #PFA. The PULSED AF Pilot Trial @atulverma_md @PrashSanders @Hu…
First-in-Human Experience and Acute Procedural Outcomes Using #PFA. The PULSED AF Pilot Trial @atulverma_md @PrashSanders @HughCalkinsMD @natale_md @GerdHindricks @CirculationEP #EPeeps
First-in-Human Experience and Acute Procedural Outcomes Using a Novel Pulsed Field Ablation System: The PULSED AF Pilot Trial #HeartMonth @CirculationEP https://t.co/vRm11iMMM9 https://t.co/g13mpue30l
RT @CirculationEP: PULSED AF Clinical Trial First-in-human Experience: 100% PVI was achieved using only PFA with no PFA system related seri…
RT @CirculationEP: PULSED AF Clinical Trial First-in-human Experience: 100% PVI was achieved using only PFA with no PFA system related seri…
RT @CirculationEP: PULSED AF Clinical Trial First-in-human Experience: 100% PVI was achieved using only PFA with no PFA system related seri…
RT @CirculationEP: PULSED AF Clinical Trial First-in-human Experience: 100% PVI was achieved using only PFA with no PFA system related seri…
RT @CirculationEP: PULSED AF Clinical Trial First-in-human Experience: 100% PVI was achieved using only PFA with no PFA system related seri…
RT @CirculationEP: PULSED AF Clinical Trial First-in-human Experience: 100% PVI was achieved using only PFA with no PFA system related seri…
RT @CirculationEP: PULSED AF Clinical Trial First-in-human Experience: 100% PVI was achieved using only PFA with no PFA system related seri…
RT @CirculationEP: PULSED AF Clinical Trial First-in-human Experience: 100% PVI was achieved using only PFA with no PFA system related seri…
RT @CirculationEP: PULSED AF Clinical Trial First-in-human Experience: 100% PVI was achieved using only PFA with no PFA system related seri…
RT @CirculationEP: PULSED AF Clinical Trial First-in-human Experience: 100% PVI was achieved using only PFA with no PFA system related seri…
RT @CirculationEP: PULSED AF Clinical Trial First-in-human Experience: 100% PVI was achieved using only PFA with no PFA system related seri…
RT @CirculationEP: PULSED AF Clinical Trial First-in-human Experience: 100% PVI was achieved using only PFA with no PFA system related seri…
RT @CirculationEP: PULSED AF Clinical Trial First-in-human Experience: 100% PVI was achieved using only PFA with no PFA system related seri…
RT @CirculationEP: PULSED AF Clinical Trial First-in-human Experience: 100% PVI was achieved using only PFA with no PFA system related seri…
RT @CirculationEP: PULSED AF Clinical Trial First-in-human Experience: 100% PVI was achieved using only PFA with no PFA system related seri…
RT @CirculationEP: PULSED AF Clinical Trial First-in-human Experience: 100% PVI was achieved using only PFA with no PFA system related seri…
PULSED AF Clinical Trial First-in-human Experience: 100% PVI was achieved using only PFA with no PFA system related serious adverse events #AHAJournals #Epeeps https://t.co/NADXbMSjq5 https://t.co/9Y9GIRlyl3
RT @S_NarayanMD: #afib PULSED AF Pilot.N=38: 160±91min (proc), 82±35min(LA dwell), 28±9min(fluoro). Congrats! @atulverma_md @PrashSanders @…
RT @S_NarayanMD: #afib PULSED AF Pilot.N=38: 160±91min (proc), 82±35min(LA dwell), 28±9min(fluoro). Congrats! @atulverma_md @PrashSanders @…
RT @S_NarayanMD: #afib PULSED AF Pilot.N=38: 160±91min (proc), 82±35min(LA dwell), 28±9min(fluoro). Congrats! @atulverma_md @PrashSanders @…
RT @S_NarayanMD: #afib PULSED AF Pilot.N=38: 160±91min (proc), 82±35min(LA dwell), 28±9min(fluoro). Congrats! @atulverma_md @PrashSanders @…
RT @S_NarayanMD: #afib PULSED AF Pilot.N=38: 160±91min (proc), 82±35min(LA dwell), 28±9min(fluoro). Congrats! @atulverma_md @PrashSanders @…
RT @S_NarayanMD: #afib PULSED AF Pilot.N=38: 160±91min (proc), 82±35min(LA dwell), 28±9min(fluoro). Congrats! @atulverma_md @PrashSanders @…
RT @S_NarayanMD: #afib PULSED AF Pilot.N=38: 160±91min (proc), 82±35min(LA dwell), 28±9min(fluoro). Congrats! @atulverma_md @PrashSanders @…
RT @S_NarayanMD: #afib PULSED AF Pilot.N=38: 160±91min (proc), 82±35min(LA dwell), 28±9min(fluoro). Congrats! @atulverma_md @PrashSanders @…
RT @S_NarayanMD: #afib PULSED AF Pilot.N=38: 160±91min (proc), 82±35min(LA dwell), 28±9min(fluoro). Congrats! @atulverma_md @PrashSanders @…
RT @S_NarayanMD: #afib PULSED AF Pilot.N=38: 160±91min (proc), 82±35min(LA dwell), 28±9min(fluoro). Congrats! @atulverma_md @PrashSanders @…
#afib PULSED AF Pilot.N=38: 160±91min (proc), 82±35min(LA dwell), 28±9min(fluoro). Congrats! @atulverma_md @PrashSanders @JohnHummelEP
Excellent procedural outcomes with PFA for AF. Significant fluoroscopy times though. First-in-Human Experience and Acute Procedural Outcomes Using a Novel Pulsed Field Ablation System: The PULSED AF Pilot Trial https://t.co/ZNspH8BSAx